Qiagen (NYSE:QGEN) Updates FY 2025 Earnings Guidance

Qiagen (NYSE:QGEN - Get Free Report) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided EPS guidance of 2.350- for the period, compared to the consensus EPS estimate of 2.290. The company issued revenue guidance of -. Qiagen also updated its FY25 guidance to ~$2.35 EPS.

Wall Street Analyst Weigh In

QGEN has been the subject of a number of analyst reports. Robert W. Baird lowered shares of Qiagen from an "outperform" rating to a "neutral" rating and cut their price objective for the company from $52.00 to $42.00 in a research report on Wednesday, February 19th. Redburn Atlantic downgraded shares of Qiagen from a "buy" rating to a "neutral" rating in a research note on Friday, April 4th. Morgan Stanley reissued an "equal weight" rating and issued a $46.67 price target (down previously from $48.61) on shares of Qiagen in a research note on Monday, January 6th. Baird R W downgraded shares of Qiagen from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 19th. Finally, UBS Group reduced their price target on shares of Qiagen from $50.00 to $48.00 and set a "neutral" rating on the stock in a research report on Friday, February 7th. Eight investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, Qiagen has an average rating of "Hold" and a consensus target price of $47.71.

Qiagen Trading Up 4.8 %

QGEN traded up $1.93 during midday trading on Friday, reaching $41.98. 1,723,550 shares of the company's stock traded hands, compared to its average volume of 1,119,244. The company has a debt-to-equity ratio of 0.38, a current ratio of 3.61 and a quick ratio of 3.09. Qiagen has a 52 week low of $37.63 and a 52 week high of $49.30. The stock has a market capitalization of $9.33 billion, a price-to-earnings ratio of 116.88, a P/E/G ratio of 2.39 and a beta of 0.62. The firm has a fifty day moving average of $39.75 and a two-hundred day moving average of $41.81.

Remove Ads

Qiagen (NYSE:QGEN - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.60 by $0.01. Qiagen had a net margin of 4.23% and a return on equity of 13.92%. On average, equities analysts anticipate that Qiagen will post 2.26 earnings per share for the current fiscal year.

Qiagen Company Profile

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.